GRCE

Grace Therapeutics (GRCE)

About Grace Therapeutics (GRCE)

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Details

Daily high

$3.66

Daily low

$3.49

Price at open

$3.51

52 Week High

$3.94

52 Week Low

$1.75

Market cap

53.8M

Dividend yield

0.00%

Volume

55,077

Avg. volume

99,617

P/E ratio

-5.95

Grace Therapeutics News